KEAP1 and infarction: Ameliorates ECG abnormalities, reduces heart/body weight ratio and infarction area; Alleviates myocardial injury and oxidative stress; Inhibits inflammatory cytokines and apoptosis; Regulates PI3K/Akt/mTOR and Keap1/Nrf2/HO-1 pathways